This trial is testing whether a pre-surgery program can improve outcomes for gynecologic cancer patients.
- Gynecologic Cancers
- Ovarian Cancer
- Endometrial Cancer
- Cervical Cancer
- Treatment Compliance
- Quality of Life
3 Primary · 5 Secondary · Reporting Duration: During the 8 weeks after surgery (12 week approximate total study period)
2 Treatment Groups
1 of 2
1 of 2
164 Total Participants · 2 Treatment Groups
Primary Treatment: Trimodal · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 90 · Female Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this clinical trial open to minors?
"This study stipulates that participants must be aged 18 or older, but no more than 90 years old." - Anonymous Online Contributor
How many participants is the maximum capacity for this medical experiment?
"Affirmative. According to information available on clinicaltrials.gov, recruitment for this medical trial is underway; it was initially posted on July 21st 2020 and most recently adjusted on April 14th 2022. A total of 164 patients are required across 1 location in order to complete the study." - Anonymous Online Contributor
Does my background qualify me to participate in this experimental research?
"In order to be eligible for the trial, individuals must meet two criteria: they must maintain treatment compliance and their age should fall between 18 - 90. Thus far, 164 people have been accepted into this experimental program." - Anonymous Online Contributor
Are registrants currently being accepted for this clinical investigation?
"Affirmative. The clinicaltrials.gov database confirms the ongoing recruitment of 164 patients at a single site for this medical trial, which was originally listed on July 21st 2020 and updated most recently on April 14th 2022." - Anonymous Online Contributor
What major goals is this research endeavor attempting to accomplish?
"The focal point of this study over the 12 week period is to quantify Grip Strength, while other metrics such as Need for Postoperative Readmission and Rate of Program Completion are also being assessed. In addition, Quality of Life will be monitored using the FACT-G (Functional Assessment of Cancer Therapy-General), which consists of 28 questions that generate a score between 0 and 112 with higher scores correlating to better quality life." - Anonymous Online Contributor